AZN

AstraZeneca PLC
D

AZN

65.635
USD
1.38
(2.15%)
Market Closed
Volume
309,880
EPS
4
Div Yield
2.26
P/E
32
Market Cap
203,508,391,246
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.14 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    748 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    104.29 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    SNY
    SNY
    0.160
    (0.33%)
    48.275 USD
    More
News

Title: AstraZeneca PLC

Sector: Healthcare
Industry: Drug Manufacturers - General
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory,cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.